ESC Premium Access

Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

Topic: Secondary Prevention

Congress Presentation

About the speaker

Ms Nicole Elise Maria Jaspers

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

14 more presentations in this session

Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

Speaker: Professor E. Bruckert (Paris, FR)


What is the most important residual risk after achievement of appropriate low-density lipoprotein cholesterol lowering therapy in secondary prevention of Japanese patients?

Speaker: Doctor A. Endo (Izumo, JP)


Association of adherence and treatment intensity of lipid-lowering therapy with cardiovascular outcomes and all-cause mortality in very high-risk patients in Germany

Speaker: Professor I. Ahrens (Cologne, DE)


Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

Speaker: Doctor O. Kobo (Hadera, IL)


Low levels of low density lipoprotein cholesterol and cardiovascular, cancer and all-cause mortality outcomes

Speaker: Professor K. Sung (Seoul, KR)


Access the full session

Poster Session 1 - Lipids

Speakers: Ms N. Jaspers, Professor E. Bruckert, Doctor A. Endo, Professor I. Ahrens, Doctor O. Kobo...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb